英文别名 |
GSK6853;GSK-6853;(R)-N-(1,3-Dimethyl-6-(2-methylpiperazin-1-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide;N-[2,3-Dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxybenzamide;GSK 6853;N-[1,3-Dimethyl-6-[(2r)-2-Methylpiperazin-1-Yl]-2-Oxidanylidene-Benzimidazol-5-Yl]-2-Methoxy-Benzamide;BCP18335;BDBM50189403;s8265;GSK6853, >=98% (HPLC);A16330;Q27462469;LF1;N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-;CS-5847;N-{1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxo-1,3-benzodiazol-5-yl}-2-methoxybenzamide;BP-25354;MFCD30489734;BS-16390;BG166666;N-[1,3-Dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxobenzimidazol-5-yl]-2-methoxybenzamide;HY-100220;EX-A1080;AKOS032944954;AC-36055;CCG-268758;SCHEMBL25445876;1910124-24-1;GSK6853?;DA-63946;CHEMBL3828191 |